SEC Form 4 · accession 0001209191-15-059231
Travere Therapeutics, Inc. · TVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jensen Margaret E Valeur
Officer — General Counsel
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 8:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $32.49 | Jul 1, 2015 | A | 60,000 | A | — | Jun 30, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable in twelve equal quarterly installments from the date of grant.